Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name Ipilimumab
Trade Name Yervoy
Synonyms BMS-734016
Drug Descriptions

Yervoy (ipilimumab) is an antibody that binds to cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4), causing increased T-cell activation (PMID: 28891423). Yervoy (ipilimumab) is FDA approved for use in patients with metastatic melanoma, including patients 12 years or older, and in combination with Opdivo (nivolumab) for intermediate or poor-risk renal cell carcinoma, microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (including patients 12 years or older), hepatocellular carcinoma previously treated with Nexavar (sorafenib), in combination with Opdivo (nivolumab) as first-line therapy in patients with PD-L1-positive (>=1%) metastatic non-small cell lung cancer without EGFR or ALK alterations, and in combination with Opdivo (nivolumab) and platinum-based chemotherapy as first-line therapy in patients with metastatic or recurrent non-small cell lung cancer without EGFR or ALK alterations (FDA.gov).
DrugClasses CTLA4 Antibody 31 Immune Checkpoint Inhibitor 149
CAS Registry Number 477202-00-9
NCIT ID C2654

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
7HP349 + Ipilimumab + Nivolumab 7HP349 Ipilimumab Nivolumab 0 1
Ad.p53-DC vaccine + Ipilimumab + Nivolumab Ad.p53-DC vaccine Ipilimumab Nivolumab 0 1
ADI-PEG 20 + Ipilimumab + Nivolumab ADI-PEG 20 Ipilimumab Nivolumab 0 1
Aldesleukin + Cyclophosphamide + Ipilimumab Aldesleukin Cyclophosphamide Ipilimumab 0 1
Aldesleukin + Ipilimumab Aldesleukin Ipilimumab 0 1
Aldesleukin + Ipilimumab + Nivolumab Aldesleukin Ipilimumab Nivolumab 0 1
Anetumab ravtansine + Ipilimumab + Nivolumab Anetumab ravtansine Ipilimumab Nivolumab 0 1
Anti-IL13RA2 CAR-T cells + Ipilimumab + Nivolumab Anti-IL13RA2 CAR-T cells Ipilimumab Nivolumab 0 1
ANV419 + Ipilimumab ANV419 Ipilimumab 0 1
Atezolizumab + Bevacizumab + Ipilimumab Atezolizumab Bevacizumab Ipilimumab 0 1
Atezolizumab + GRT-C901 + GRT-R902 + Ipilimumab Atezolizumab GRT-C901 GRT-R902 Ipilimumab 0 2
Atezolizumab + Ipilimumab Atezolizumab Ipilimumab 0 1
Atezolizumab + Ipilimumab + Tiragolumab Atezolizumab Ipilimumab Tiragolumab 0 1
Axitinib + Ipilimumab Axitinib Ipilimumab 0 1
Axitinib + Ipilimumab + Nivolumab Axitinib Ipilimumab Nivolumab 0 1
Bevacizumab + Ipilimumab Bevacizumab Ipilimumab 0 1
Bicalutamide + Ipilimumab + Nivolumab Bicalutamide Ipilimumab Nivolumab 0 1
Binimetinib + Encorafenib + Ipilimumab + Nivolumab Binimetinib Encorafenib Ipilimumab Nivolumab 0 1
Binimetinib + Ipilimumab + Nivolumab Binimetinib Ipilimumab Nivolumab 0 1
Blinatumomab + Ipilimumab + Nivolumab Blinatumomab Ipilimumab Nivolumab 0 1
BMS-986156 + Ipilimumab + Nivolumab BMS-986156 Ipilimumab Nivolumab 0 1
BMS-986178 + Ipilimumab BMS-986178 Ipilimumab 0 0
BMS-986178 + Ipilimumab + Nivolumab BMS-986178 Ipilimumab Nivolumab 0 0
BMS-986207 + Ipilimumab + Nivolumab BMS-986207 Ipilimumab Nivolumab 0 1
BMS-986226 + Ipilimumab BMS-986226 Ipilimumab 0 1
BMS-986299 + Ipilimumab + Nivolumab BMS-986299 Ipilimumab Nivolumab 0 1
BMS-986408 + Ipilimumab + Nivolumab BMS-986408 Ipilimumab Nivolumab 0 1
Brentuximab vedotin + Ipilimumab Brentuximab vedotin Ipilimumab 0 1
Cabazitaxel + Carboplatin + Ipilimumab + Nivolumab Cabazitaxel Carboplatin Ipilimumab Nivolumab 0 1
Cabozantinib + Ipilimumab + Nivolumab Cabozantinib Ipilimumab Nivolumab 0 16
Camu camu + Ipilimumab + Nivolumab Camu camu Ipilimumab Nivolumab 0 1
Canerpaturev + Ipilimumab Canerpaturev Ipilimumab 0 1
Capecitabine + Ipilimumab + Nivolumab Capecitabine Ipilimumab Nivolumab 0 1
Carboplatin + Ipilimumab + Nivolumab + Paclitaxel Carboplatin Ipilimumab Nivolumab Paclitaxel 0 4
Carboplatin + Ipilimumab + Nivolumab + Pemetrexed Disodium Carboplatin Ipilimumab Nivolumab Pemetrexed Disodium 0 3
Carboplatin + Ipilimumab + Paclitaxel Carboplatin Ipilimumab Paclitaxel 0 1
CBL0137 + Ipilimumab + Nivolumab CBL0137 Ipilimumab Nivolumab 0 1
CBM588 + Ipilimumab + Nivolumab CBM588 Ipilimumab Nivolumab 0 2
CD24Fc + Ipilimumab + Nivolumab CD24Fc Ipilimumab Nivolumab 0 1
Celecoxib + Ipilimumab + Nivolumab Celecoxib Ipilimumab Nivolumab 0 1
Cemiplimab + Fianlimab + Ipilimumab Cemiplimab Fianlimab Ipilimumab 0 1
Cemiplimab + Ipilimumab Cemiplimab Ipilimumab 0 4
Cemiplimab + Ipilimumab + VSV-hIFNbeta-NIS Cemiplimab Ipilimumab VSV-hIFNbeta-NIS 0 1
Cetuximab + Ipilimumab Cetuximab Ipilimumab 0 1
CIML-NK cells + Ipilimumab + Nogapendekin alfa inbakicept CIML-NK cells Ipilimumab Nogapendekin alfa inbakicept 0 1
Cisplatin + Etoposide + Ipilimumab Cisplatin Etoposide Ipilimumab 0 1
Cisplatin + Ipilimumab + Nivolumab + Pemetrexed Disodium Cisplatin Ipilimumab Nivolumab Pemetrexed Disodium 0 2
Cisplatin + Ipilimumab + Pemetrexed Disodium Cisplatin Ipilimumab Pemetrexed Disodium 0 1
Citarinostat + Ipilimumab + Nivolumab Citarinostat Ipilimumab Nivolumab 0 2
Cobimetinib + Ipilimumab + Nivolumab Cobimetinib Ipilimumab Nivolumab 0 1
Copanlisib + Ipilimumab + Nivolumab Copanlisib Ipilimumab Nivolumab 0 1
Coxsackievirus A21 + Ipilimumab Coxsackievirus A21 Ipilimumab 0 1
CP-506 + Ipilimumab CP-506 Ipilimumab 0 1
CPI-1205 + Ipilimumab CPI-1205 Ipilimumab 0 1
CPI-444 + Ipilimumab + Nivolumab CPI-444 Ipilimumab Nivolumab 0 1
Crizotinib + Ipilimumab Crizotinib Ipilimumab 0 1
CRS-207 + Cyclophosphamide + GVAX pancreatic cancer vaccine + Ipilimumab + Nivolumab CRS-207 Cyclophosphamide GVAX pancreatic cancer vaccine Ipilimumab Nivolumab 0 1
CRS-207 + Ipilimumab + Nivolumab CRS-207 Ipilimumab Nivolumab 0 1
CRS-207 + Ipilimumab + Pembrolizumab + Tadalafil CRS-207 Ipilimumab Pembrolizumab Tadalafil 0 1
CX-072 + Ipilimumab CX-072 Ipilimumab 0 1
Cyclophosphamide + Interferon alpha-2b + Ipilimumab + SV-BR-1-GM Cyclophosphamide Interferon alpha-2b Ipilimumab SV-BR-1-GM 0 1
Cyclophosphamide + Ipilimumab + Nivolumab Cyclophosphamide Ipilimumab Nivolumab 0 1
Cyclophosphamide + Ipilimumab + Pembrolizumab + Sargramostim Cyclophosphamide Ipilimumab Pembrolizumab Sargramostim 0 1
Dabrafenib + Ipilimumab Dabrafenib Ipilimumab 0 3
Dabrafenib + Ipilimumab + Nivolumab Dabrafenib Ipilimumab Nivolumab 0 1
Dabrafenib + Ipilimumab + Nivolumab + Trametinib Dabrafenib Ipilimumab Nivolumab Trametinib 0 1
Dabrafenib + Ipilimumab + Trametinib Dabrafenib Ipilimumab Trametinib 0 2
Dactinomycin + Ipilimumab + Melphalan Dactinomycin Ipilimumab Melphalan 0 1
Dasatinib + Ipilimumab Dasatinib Ipilimumab 0 1
DC tumor cell lysate vaccine + Ipilimumab + Nivolumab + Poly ICLC DC tumor cell lysate vaccine Ipilimumab Nivolumab Poly ICLC 0 1
Decitabine + Ipilimumab Decitabine Ipilimumab 0 1
Denosumab + Ipilimumab + Nivolumab Denosumab Ipilimumab Nivolumab 0 1
DNAJB1-PRKACA peptide vaccine + Ipilimumab + MUC1 peptide-Poly-ICLC vaccine + Nivolumab DNAJB1-PRKACA peptide vaccine Ipilimumab MUC1 peptide-Poly-ICLC vaccine Nivolumab 0 0
DNAJB1-PRKACA peptide vaccine + Ipilimumab + Nivolumab + Poly ICLC DNAJB1-PRKACA peptide vaccine Ipilimumab Nivolumab Poly ICLC 0 1
DS-3201b + Ipilimumab DS-3201b Ipilimumab 0 1
Encorafenib + Ipilimumab + Nivolumab Encorafenib Ipilimumab Nivolumab 0 1
Entinostat + Ipilimumab + Nivolumab Entinostat Ipilimumab Nivolumab 0 2
Envafolimab + Ipilimumab Envafolimab Ipilimumab 0 1
Epacadostat + Ipilimumab + Nivolumab Epacadostat Ipilimumab Nivolumab 0 1
Erlotinib + Ipilimumab Erlotinib Ipilimumab 0 1
Evofosfamide + Ipilimumab Evofosfamide Ipilimumab 0 1
Evolocumab + Ipilimumab + Nivolumab Evolocumab Ipilimumab Nivolumab 0 1
Fluorouracil + Ipilimumab + Leucovorin + Nivolumab + Oxaliplatin Fluorouracil Ipilimumab Leucovorin Nivolumab Oxaliplatin 0 1
Fluorouracil + Ipilimumab + Nivolumab Fluorouracil Ipilimumab Nivolumab 0 1
FLX475 + Ipilimumab FLX475 Ipilimumab 0 1
Gavocabtagene autoleucel + Ipilimumab + Nivolumab Gavocabtagene autoleucel Ipilimumab Nivolumab 0 1
Gemcitabine + Hydroxychloroquine + Ipilimumab Gemcitabine Hydroxychloroquine Ipilimumab 0 0
Gemcitabine + Hydroxychloroquine + Ipilimumab + Nab-paclitaxel Gemcitabine Hydroxychloroquine Ipilimumab Nab-paclitaxel 0 1
Gemcitabine + Ipilimumab Gemcitabine Ipilimumab 0 1
Gemcitabine + Ipilimumab + Nab-paclitaxel + Nivolumab Gemcitabine Ipilimumab Nab-paclitaxel Nivolumab 0 1
Gemcitabine + Ipilimumab + Nivolumab Gemcitabine Ipilimumab Nivolumab 0 0
GNOS-PV01 + INO-9012 + Ipilimumab + Nivolumab GNOS-PV01 INO-9012 Ipilimumab Nivolumab 0 0
GRT-C901 + GRT-R902 + Ipilimumab + Nivolumab GRT-C901 GRT-R902 Ipilimumab Nivolumab 0 1
GRT-C903 + GRT-R904 + Ipilimumab + Nivolumab GRT-C903 GRT-R904 Ipilimumab Nivolumab 0 1
Guadecitabine + Ipilimumab + Nivolumab Guadecitabine Ipilimumab Nivolumab 0 1
GVAX + Ipilimumab + Nivolumab GVAX Ipilimumab Nivolumab 0 1
GVAX pancreatic cancer vaccine + Ipilimumab GVAX pancreatic cancer vaccine Ipilimumab 0 0
hu14.18-IL2 + Ipilimumab + Nivolumab Ipilimumab Nivolumab hu14.18-IL2 0 1
Hydroxychloroquine + Ipilimumab Hydroxychloroquine Ipilimumab 0 0
Hydroxychloroquine + Ipilimumab + Nab-paclitaxel Hydroxychloroquine Ipilimumab Nab-paclitaxel 0 0
Hydroxychloroquine + Ipilimumab + Nivolumab Hydroxychloroquine Ipilimumab Nivolumab 0 1
Ibrutinib + Ipilimumab Ibrutinib Ipilimumab 0 1
Ibrutinib + Ipilimumab + Nivolumab Ibrutinib Ipilimumab Nivolumab 0 1
Imatinib + Ipilimumab Imatinib Ipilimumab 0 1
IMO-2125 + Ipilimumab IMO-2125 Ipilimumab 0 2
IMO-2125 + Ipilimumab + Nivolumab IMO-2125 Ipilimumab Nivolumab 0 2
INCAGN01876 + Ipilimumab INCAGN01876 Ipilimumab 0 1
INCAGN01876 + Ipilimumab + Nivolumab INCAGN01876 Ipilimumab Nivolumab 0 1
INCAGN01949 + Ipilimumab INCAGN01949 Ipilimumab 0 1
INCAGN01949 + Ipilimumab + Nivolumab INCAGN01949 Ipilimumab Nivolumab 0 1
INCB099280 + Ipilimumab INCB099280 Ipilimumab 0 1
Ipilimumab Ipilimumab 0 92
Ipilimumab + Ivosidenib + Nivolumab Ipilimumab Ivosidenib Nivolumab 0 1
Ipilimumab + JX-594 Ipilimumab JX-594 0 1
Ipilimumab + Lefitolimod Ipilimumab Lefitolimod 0 1
Ipilimumab + Lenalidomide Ipilimumab Lenalidomide 0 2
Ipilimumab + Linrodostat + Nivolumab Ipilimumab Linrodostat Nivolumab 0 1
Ipilimumab + LMB-100 Ipilimumab LMB-100 0 1
Ipilimumab + Lurbinectedin + Nivolumab Ipilimumab Lurbinectedin Nivolumab 0 1
Ipilimumab + lutetium Lu 177 vipivotide tetraxetan Ipilimumab lutetium Lu 177 vipivotide tetraxetan 0 1
Ipilimumab + lutetium Lu 177 vipivotide tetraxetan + Nivolumab Ipilimumab Nivolumab lutetium Lu 177 vipivotide tetraxetan 0 1
Ipilimumab + MaaT013 + Nivolumab Ipilimumab MaaT013 Nivolumab 0 1
Ipilimumab + MAQ-001 Ipilimumab MAQ-001 0 1
Ipilimumab + Mebendazole + Nivolumab + Sorafenib Ipilimumab Mebendazole Nivolumab Sorafenib 0 0
Ipilimumab + Melphalan + Nivolumab Ipilimumab Melphalan Nivolumab 0 2
Ipilimumab + MGA271 Ipilimumab MGA271 0 1
Ipilimumab + MIW815 Ipilimumab MIW815 0 1
Ipilimumab + Mocetinostat + Nivolumab Ipilimumab Mocetinostat Nivolumab 0 1
Ipilimumab + Nab-paclitaxel Ipilimumab Nab-paclitaxel 0 1
Ipilimumab + Nab-paclitaxel + Nivolumab Ipilimumab Nab-paclitaxel Nivolumab 0 1
Ipilimumab + NBTXR3 + Nivolumab Ipilimumab NBTXR3 Nivolumab 0 1
Ipilimumab + NEO-PV-01 + Nivolumab + Poly ICLC Ipilimumab NEO-PV-01 Nivolumab Poly ICLC 0 1
Ipilimumab + NEO212 Ipilimumab NEO212 0 1
Ipilimumab + NeoVax Ipilimumab NeoVax 0 1
Ipilimumab + NeoVax + Nivolumab Ipilimumab NeoVax Nivolumab 0 2
Ipilimumab + Nintedanib + Nivolumab Ipilimumab Nintedanib Nivolumab 0 1
Ipilimumab + Niraparib Ipilimumab Niraparib 0 1
Ipilimumab + Nivolumab Ipilimumab Nivolumab 35 240
Ipilimumab + Nivolumab + Oxaliplatin Ipilimumab Nivolumab Oxaliplatin 0 1
Ipilimumab + Nivolumab + Paclitaxel Ipilimumab Nivolumab Paclitaxel 0 1
Ipilimumab + Nivolumab + Panitumumab Ipilimumab Nivolumab Panitumumab 0 1
Ipilimumab + Nivolumab + Pepinemab Ipilimumab Nivolumab Pepinemab 0 1
Ipilimumab + Nivolumab + Plinabulin Ipilimumab Nivolumab Plinabulin 0 1
Ipilimumab + Nivolumab + Poly ICLC Ipilimumab Nivolumab Poly ICLC 0 1
Ipilimumab + Nivolumab + Poly ICLC + Pooled Mutant KRAS-Targeted Long Peptide Vaccine Ipilimumab Nivolumab Poly ICLC Pooled Mutant KRAS-Targeted Long Peptide Vaccine 0 2
Ipilimumab + Nivolumab + Pooled Mutant KRAS-Targeted Long Peptide Vaccine Ipilimumab Nivolumab Pooled Mutant KRAS-Targeted Long Peptide Vaccine 0 0
Ipilimumab + Nivolumab + Prednisone + Sirolimus Ipilimumab Nivolumab Prednisone Sirolimus 0 1
Ipilimumab + Nivolumab + Prednisone + Tacrolimus Ipilimumab Nivolumab Prednisone Tacrolimus 0 1
Ipilimumab + Nivolumab + PROSTVAC-F-TRICOM + PROSTVAC-V-TRICOM Ipilimumab Nivolumab PROSTVAC-F-TRICOM PROSTVAC-V-TRICOM 0 2
Ipilimumab + Nivolumab + PROSTVAC-V-TRICOM Ipilimumab Nivolumab PROSTVAC-V-TRICOM 0 0
Ipilimumab + Nivolumab + Regorafenib Ipilimumab Nivolumab Regorafenib 0 1
Ipilimumab + Nivolumab + Relatlimab Ipilimumab Nivolumab Relatlimab 0 1
Ipilimumab + Nivolumab + rhIL-15 Ipilimumab Nivolumab rhIL-15 0 1
Ipilimumab + Nivolumab + rHuPH20 Ipilimumab Nivolumab rHuPH20 0 1
Ipilimumab + Nivolumab + Rituximab Ipilimumab Nivolumab Rituximab 0 1
Ipilimumab + Nivolumab + Rovalpituzumab Tesirine Ipilimumab Nivolumab Rovalpituzumab Tesirine 0 1
Ipilimumab + Nivolumab + Sacituzumab govitecan-hziy Ipilimumab Nivolumab Sacituzumab govitecan-hziy 0 1
Ipilimumab + Nivolumab + Sargramostim + UV1 Telomerase peptide vaccine Ipilimumab Nivolumab Sargramostim UV1 Telomerase peptide vaccine 0 1
Ipilimumab + Nivolumab + SCIB1 Ipilimumab Nivolumab SCIB1 0 1
Ipilimumab + Nivolumab + SD-101 Ipilimumab Nivolumab SD-101 0 2
Ipilimumab + Nivolumab + Sitravatinib Ipilimumab Nivolumab Sitravatinib 0 1
Ipilimumab + Nivolumab + Sotigalimab Ipilimumab Nivolumab Sotigalimab 0 1
Ipilimumab + Nivolumab + SQZ-AAC-HPV Ipilimumab Nivolumab SQZ-AAC-HPV 0 1
Ipilimumab + Nivolumab + Talimogene laherparepvec Ipilimumab Nivolumab Talimogene laherparepvec 0 1
Ipilimumab + Nivolumab + Tazemetostat Ipilimumab Nivolumab Tazemetostat 0 1
Ipilimumab + Nivolumab + Temozolomide Ipilimumab Nivolumab Temozolomide 0 1
Ipilimumab + Nivolumab + Temsirolimus Ipilimumab Nivolumab Temsirolimus 1 0
Ipilimumab + Nivolumab + TGF-beta-15 peptide vaccine Ipilimumab Nivolumab TGF-beta-15 peptide vaccine 0 1
Ipilimumab + Nivolumab + Thymoquinone Ipilimumab Nivolumab Thymoquinone 0 1
Ipilimumab + Nivolumab + Tocilizumab Ipilimumab Nivolumab Tocilizumab 0 2
Ipilimumab + Nivolumab + TP-1454 Ipilimumab Nivolumab TP-1454 0 1
Ipilimumab + Nivolumab + Trabectedin Ipilimumab Nivolumab Trabectedin 0 1
Ipilimumab + Nivolumab + Trametinib Ipilimumab Nivolumab Trametinib 0 2
Ipilimumab + Nivolumab + Trigriluzole Ipilimumab Nivolumab Trigriluzole 0 1
Ipilimumab + Nivolumab + UV1 Telomerase peptide vaccine Ipilimumab Nivolumab UV1 Telomerase peptide vaccine 0 1
Ipilimumab + Nivolumab + Vedolizumab Ipilimumab Nivolumab Vedolizumab 0 1
Ipilimumab + Nivolumab + XL092 Ipilimumab Nivolumab XL092 0 1
Ipilimumab + Nivolumab + Yttrium-90 microsphere therapy Ipilimumab Nivolumab Yttrium-90 microsphere therapy 0 1
Ipilimumab + Nivolumab + ZEN-3694 Ipilimumab Nivolumab ZEN-3694 0 1
Ipilimumab + Nivolumab and relatlimab-rmbw + Sarilumab Ipilimumab Nivolumab and relatlimab-rmbw Sarilumab 0 1
Ipilimumab + Nogapendekin alfa inbakicept Ipilimumab Nogapendekin alfa inbakicept 0 0
Ipilimumab + NY-ESO-1 peptide vaccine Ipilimumab NY-ESO-1 peptide vaccine 0 0
Ipilimumab + Osimertinib Ipilimumab Osimertinib 0 1
Ipilimumab + Pembrolizumab Ipilimumab Pembrolizumab 0 6
Ipilimumab + Pembrolizumab + Sargramostim Ipilimumab Pembrolizumab Sargramostim 0 1
Ipilimumab + Pepinemab Ipilimumab Pepinemab 0 4
Ipilimumab + Pexmetinib Ipilimumab Pexmetinib 0 1
Ipilimumab + PROSTVAC-F-TRICOM + PROSTVAC-V-TRICOM Ipilimumab PROSTVAC-F-TRICOM PROSTVAC-V-TRICOM 0 2
Ipilimumab + PROSTVAC-V-TRICOM Ipilimumab PROSTVAC-V-TRICOM 0 0
Ipilimumab + Radiotherapy Ipilimumab Radiotherapy 0 0
Ipilimumab + Relatlimab Ipilimumab Relatlimab 0 1
Ipilimumab + RGX-104 Ipilimumab RGX-104 0 1
Ipilimumab + rhIL-15 Ipilimumab rhIL-15 0 1
Ipilimumab + Sargramostim + UV1 Telomerase peptide vaccine Ipilimumab Sargramostim UV1 Telomerase peptide vaccine 0 0
Ipilimumab + SD-101 Ipilimumab SD-101 0 1
Ipilimumab + Sitravatinib Ipilimumab Sitravatinib 0 1
Ipilimumab + SQZ-AAC-HPV Ipilimumab SQZ-AAC-HPV 0 1
Ipilimumab + Tiragolumab Ipilimumab Tiragolumab 0 1
Ipilimumab + TMV vaccine Ipilimumab TMV vaccine 0 1
Ipilimumab + Trametinib Ipilimumab Trametinib 0 1
Ipilimumab + VAC85135 Ipilimumab VAC85135 0 1
Ipilimumab + Vopratelimab Ipilimumab Vopratelimab 0 2


Additional content available in CKB BOOST